Proteasomal degradation of polycomb-group protein CBX6 confers MMP-2 expression essential for mesothelioma invasion.
Katsuya SakaiTakumi NishiuchiShoichiro TangeYoshinori SuzukiSeiji YanoMinoru TerashimaTakeshi SuzukiKunio MatsumotoPublished in: Scientific reports (2020)
The aggressive invasiveness of malignant mesothelioma limits cancer therapy, however, the molecular mechanisms underlying the invasiveness remain largely unknown. Here we found that the matrix metalloproteinase-2 (MMP-2) was required for the invasion of mesothelioma cells in the collagen matrix and the gene expression of MMP-2 was correlated with the invasive phenotype. The MMP-2 gene expression was regulated by DNA and histone methylation around the transcription start site, implicating the involvement of the polycomb repressive complex (PRC). Knockdown of PRC component chromobox 6 (CBX6) promoted MMP-2 expression and invasion of mesothelioma cells. Transcriptome analysis suggested that CBX6 regulates sets of genes involved in cancer cell migration and metastasis. In invasive but not non-invasive cells, CBX6 was constantly unstable owing to ubiquitination and protein degradation. In human tissues, CBX6 localized in the nuclei of normal mesothelium and benign mesothelioma, but the nuclear staining of CBX6 was lost in malignant mesothelioma. These results suggest involvement of proteasomal degradation of CBX6 in mesothelioma progression.
Keyphrases
- cell migration
- gene expression
- induced apoptosis
- dna methylation
- cell cycle arrest
- poor prognosis
- binding protein
- endothelial cells
- drug delivery
- small molecule
- oxidative stress
- transcription factor
- young adults
- squamous cell carcinoma
- amino acid
- papillary thyroid
- genome wide
- cell proliferation
- protein protein
- circulating tumor
- tissue engineering
- squamous cell
- pluripotent stem cells
- childhood cancer